Connect with us
European Gaming Congress 2024

Artificial Intelligence

Global ePharmacy Market Size 2021 | To Exhibit a CAGR of 17.3% and Hit USD 177,794.9 Million; Growth Opportunities Witnessed Around the World to Support Expansion by 2026

Published

on

Pune, India, April 21, 2021 (GLOBE NEWSWIRE) — According to the World Bank, approximately 84% populace in Germany depend on Internet and around 75% populace in the U.S. are subscribers of the Internet, which augments the global ePharmacy market growth. Fortune Business Insights states that the global ePharmacy market is projected to reach US$ 177,794.9 Mn by 2026, thereby exhibiting an impressive CAGR of 17.3% during the forecast period (2019-2026). The company further states that the global market was valued at US$ 49,727.7 Mn in 2018. According to a published report by Fortune Business Insights, titled, “ePharmacy: Global Market Analysis, Insights and Forecast, 2019-2026,” the global ePharmacy market will witness notable growth during the forecast period due to the technological advancements based on artificial intelligence.

Request a Sample Copy of Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/epharmacy-market-100238

Increasing Adoption of E-commerce Websites to Favor Growth in Asia Pacific

Geographically, the global ePharmacy market is grouped into Asia Pacific, North America, the Middle East and Africa, Europe, and Latin America. Out of these regions, North America is expected to remain in the leading position in the global ePharmacy market during the forecast period. The growth is attributed to the rapid shift of consumers towards online retailers from offline pharmacies. Also, increasing usage of smartphones and high speed of the Internet are expected to aid North America in gaining the highest global ePharmacy market share in the forthcoming years. Furthermore, a rise in geriatric population, increasing online orders, and growing adoption of online platforms will drive the market growth in this region.

Europe and Asia Pacific, on the other hand, are projected to exhibit significantly high CAGR during the forecast period. In Europe, numerous prominent market players have begun offering products at lucrative rates. This will positively impact growth of ePharmacy market in this region. Asia Pacific, on the other hand, has been witnessing higher adoption of e-commerce websites and increasing patient pool. Moreover, the healthcare infrastructure in this region is on the verge of becoming prosperous. All these factors are anticipated to fuel ePharmacy market growth in Asia Pacific in the coming years.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/epharmacy-market-100238

Advertisement

The recent coronavirus outbreak has brought major businesses to a standstill. Due to travel bans, companies in this sector are likely to take a huge hit in the coming years. Ultimately, the rapid spread of the disease has urged governments to take strict measures. The report includes the impact on Covid-19 pandemic on the global Pharmaceuticals market and discusses how major companies are coping with this.

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market. Furthermore, the report offers a detailed analysis and information as per Pharmaceuticals Market Growth Analysis by manufacturers, market segments helping our readers to get a comprehensive overview of the global market. Several players are planning to focus on developing cost-effective products or services, aiming to maintain a strong foothold in the market.

Quick Buy ePharmacy Market Research Report:  https://www.fortunebusinessinsights.com/checkout-page/100238

Key Market Players to Focus on Bagging Funds for Expanding Online Platforms 

Several key market players operating in the global ePharmacy market have begun exploring and implementing new strategies to provide the consumers with smooth service. Fortune Business Insights has listed a few key developments that have occurred in the global ePharmacy market since the past few years:

Advertisement
  • Meds, a Swedish online pharmacy announced in January 2019 that it raised US$ 5.5 million in a funding round conducted by Inbox Capital, a family-owned venture capital company, headquartered in Sweden. The total amount of the startup has increased to US$ 10.5 million. Meds sells healthcare, beauty products, prescription, and non-prescription drugs. They have received permission from the Swedish Medical Product Agency to sell those. According to the company, approximately 40% of the sales come from the households in the Stockholm area as the home delivery service takes less than two hours. After receiving the funds, the company declared that it would soon expand their area of delivery to both Gothenburg and Malmö. Also, the company has planned to expand its warehouse area.

The Report Lists the Key Players in this Market:

•              DocMorris

•              CVS Health Corporation

•              Express Script Holding Company

•              Walgreen Co.

•              Optum Rx, Inc.

Advertisement

•              Giant Eagle, Inc.

•              Walmart Stores, Inc.

•              Rowland Pharmacy

•              The Kroger Co.

•              Other players

Advertisement

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/epharmacy-market-100238

Detailed Table of Content:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Key Start-ups and Funding Overview
    • Key Industry Developments – Mergers, Acquisitions, and Partnerships, 2018
    • Overview of Regulatory Scenario – Key Countries
    • Key Industry Trends
    • Overview of e-Commerce Penetration – Key Countries
  • Global ePharmacy Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Product
      • Over-the-Counter Products
      • Prescription Medicine
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia Pacific
      • Rest of World
  • North America ePharmacy Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis – By Product
      • Over-the-Counter Products
      • Prescription Medicine
    • Market Analysis – By Country
      • U.S.
      • Canada
  • Europe ePharmacy Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis – By Product
      • Over-the-Counter Products
      • Prescription Medicine
    • Market Analysis – By Country/Sub-region
      • U.K.
      • Germany
      • France
      • Spain
      • Italy
      • Scandinavia

TOC Continued….!!!

Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/epharmacy-market-100238

Have a Look at Related Reports:

Thin Film Drugs Market Size, Share & COVID-19 Impact Analysis, By Drug Type (Oral Thin Film Drugs and Transdermal Thin Film Drugs), By Disease Indication (Schizophrenia, Migraine, Opioid Dependence, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Regional Forecast, 2021-2028

Advertisement

Anxiety Disorders and Depression Treatment Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Antidepressants, Anxiolytics, Anticonvulsants, Noradrenergic Agents, and Atypical Antipsychotics), By Indication (Anxiety and Depression), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027

Respiratory Syncytial Virus Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Prophylaxis and Treatment), By End-user (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Regional Forecast, 2020-2027

Veterinary Drugs Market Size, Share and Industry Analysis by Product (Anti-infectives, Anti-inflammatory, Parasiticides, Others), By Animal (Companion, Livestock), By Route of Administration (Oral, Parenteral,Topical), Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, Others,) and Regional Forecast, 2018 – 2025

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Advertisement

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: [email protected]m
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Advertisement

Press: https://www.fortunebusinessinsights.com/press-release/epharmacy-market-9262

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Relu Secures FDA 510(k) and CE Marking for Revolutionary Dental Software Relu® Creator

Published

on

relu-secures-fda-510(k)-and-ce-marking-for-revolutionary-dental-software-relu-creator

LEUVEN, Belgium, Oct. 1, 2024 /PRNewswire/ — Relu, a pioneer in artificial intelligence (AI) assisted segmentation for dental labs and software companies, proudly announces the dual achievement of 510(k) clearance by the U.S. Food and Drug Administration (FDA) and CE Mark approval by an EU Notified Body. These regulatory milestones authorize the commercial distribution of the Relu® Creator, the cutting-edge dental tool that enables users to create 3D anatomical models from patients in just minutes.

 
 
FDA clearance signifies compliance with U.S. medical device standards, while the CE Mark confirms adherence to EU regulations for product safety and consumer protection. This dual recognition underscores Relu’s commitment to excellence in the oral health sector.
“We are thrilled to have attained both FDA and CE approval for the Relu® Creator,” stated Adriaan Van Gerven, CTO and Co-founder, of Relu. “These significant achievements are a testament to Relu’s dedication to creating superior technology that meets the highest international safety and quality standards. We’re poised to revolutionize patient and dentist experiences across both continents.”
“This approval paves the way for our advanced technology to enter US and EU dental markets with the highest potential for growth. Having led strategy in Dental, AI and Orthodontic sectors, I consider this achievement a key differentiator that sets Relu® Creator apart. This is a major step forward in Relu’s mission to modernize dental care,” said Bindu Saran, former Global Head of Orthodontic Technology at Straumann, former Sr. Manager of R&D at Ormco, and Board Member at Relu.
The Relu® Creator integrates cutting-edge AI to deliver features such as automated anatomical identification, and enhanced 3D imaging for dental diagnostics and treatment planning. By improving precision and increasing overall efficiency in dental procedures, Relu® Creator is set to be an essential tool for modern dental clinics.
About Relu
Relu is founded in 2019 with the dream of making dental treatments safer and faster. They plug in advanced computer vision and artificial intelligence to automate manual workflows. Their Relu® Engine and Relu® Creator are used by dental lab and software partners for more than thousands of orthodontic and implant treatments every day. Relu is headquartered in Leuven, BE with an office in Boston, MA, USA. Learn more at relu.eu.
© 2024 Relu
Photo: https://mma.prnewswire.com/media/2503063/Relu.jpgLogo: https://mma.prnewswire.com/media/2038266/Relu_Logo.jpg
 
 

View original content:https://www.prnewswire.co.uk/news-releases/relu-secures-fda-510k-and-ce-marking-for-revolutionary-dental-software-relu-creator-302246365.html

Continue Reading

Artificial Intelligence

Danish telecoms giant TDC NET chooses IFS Cloud to boost workforce efficiency and modernize infrastructure

Published

on

danish-telecoms-giant-tdc-net-chooses-ifs-cloud-to-boost-workforce-efficiency-and-modernize-infrastructure

LONDON, Oct. 1, 2024 /PRNewswire/ — IFS, the leading provider of enterprise cloud and Industrial AI software, today announced that TDC NET, Denmark’s largest provider of telecommunications infrastructure, has chosen to implement IFS Cloud to supercharge operational efficiencies across its business.

A longstanding IFS customer, TDC Net will use the IFS Cloud for Field Service Management to streamline its workforce management (WFM) processes, including field service operations. Implementing IFS Cloud will also allow the Danish telco company to consolidate its WFM systems into a single platform, eliminating process duplication and controlling costs.
IFS Cloud for Field Service Management including IFS Planning and Scheduling Optimization (IFS PSO) will allow TDC NET to assign the right technicians with the appropriate skills to the right jobs and dynamically schedule tasks based on real-time data such as technician availability, location, and traffic conditions. This enhanced efficiency is critical as TDC NET continues its mission to transition its nationwide network infrastructure from copper to fiber, implement IoT solutions, and adopt AI technologies – all in a sustainable way to reach the company’s net zero target in 2030.
Beyond workforce management IFS Cloud will enable TDC NET to consolidate its wider IT operations, removing legacy infrastructure and reducing the number of current systems across the business.
Carsten Rasmussen, Head of IT enablement in TDC Net, said: “As we work towards phasing out copper infrastructure and becoming a modern digital infrastructure provider, consolidating our IT systems is critical. Partnering with IFS and accessing IFS Cloud will give us the field service and resource management capabilities we need to simplify, automate, and build a sustainable architecture that meets the demands of the new digital age.”
Jesper Illum, Country Manager, Denmark, IFS, said: “TDC Net is not only Denmark’s largest provider of telecommunications infrastructure but also a forward-thinking company committed to transforming its operations with fiber and 5G technologies. IFS Cloud will help it scale its systems, increase automation, and improve customer deliveries.”
IFS partner, Infosys, will implement and roll out IFS Cloud and the associated services.
About TDC NET
TDC NET is a Danish telecommunications company focused on building, operating and maintaining telecommunications infrastructure in Denmark. It provides a wide range of services, including fiber broadband and the best 5G mobile network in Denmark. TDC NET plays a key role in digitalising Denmark by investing in and upgrading network infrastucture to ensure high-quality connectivity and access for both individuals and businesses. For more information, please visit tdcnet.com
About IFS
IFS is the world’s leading provider of Industrial AI and enterprise software for hardcore businesses that make, service, and power our planet. Our technology enables businesses which manufacture goods, maintain complex assets, and manage service-focused operations to unlock the transformative power of Industrial AI™ to enhance productivity, efficiency, and sustainability.IFS Cloud is a fully composable AI-powered platform, designed for ultimate flexibility and adaptability to our customers’ specific requirements and business evolution. It spans the needs of Enterprise Resource Planning (ERP), Enterprise Asset Management (EAM), Supply Chain Management (SCM), Information Technology Service Management (ITSM), and Field Service Management (FSM). IFS technology leverages AI, machine learning, real-time data and analytics to empower our customers to make informed strategic decisions and excel at their Moment of Service™.IFS was founded in 1983 by five university friends who pitched a tent outside our first customer’s site to ensure they would be available 24/7 and the needs of the customer would come first. Since then, IFS has grown into a global leader with over 6,500 employees in 80 countries. Driven by those foundational values of agility, customer-centricity, and trust, IFS is recognized worldwide for delivering value and supporting strategic transformations. We are the most recommended supplier in our sector. Visit ifs.com to learn why.
IFS Press Contacts:
Europe / MEA / APJ: Adam GillbeIFS, Director of Corporate & Executive CommunicationsEmail: [email protected] Phone: +44 7775 114 856
North America / LATAM: Mairi MorganIFS, Director of Corporate & Executive CommunicationsEmail: [email protected] Phone: +44 7918 607 299
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/ifs/r/danish-telecoms-giant-tdc-net-chooses-ifs-cloud-to-boost-workforce-efficiency-and-modernize-infrastr,c4045209
The following files are available for download:
https://mb.cision.com/Main/855/4045209/3031626.pdf
Release
https://news.cision.com/ifs/i/teknikerbil-kornmark-930x423px,c3338713
teknikerbil kornmark 930x423px

View original content:https://www.prnewswire.co.uk/news-releases/danish-telecoms-giant-tdc-net-chooses-ifs-cloud-to-boost-workforce-efficiency-and-modernize-infrastructure-302263739.html

Continue Reading

Artificial Intelligence

TraceLink Releases Amadeus, the First Generative AI Assistant for Accelerating the Digitalization of Supply Networks on the Opus Platform

Published

on

tracelink-releases-amadeus,-the-first-generative-ai-assistant-for-accelerating-the-digitalization-of-supply-networks-on-the-opus-platform

Trained on a rich set of information from a unified content repository, Opus Orchestration Architects, Solution Designers, Network Administrators, and those simply interested in learning more about TraceLink’s solutions are empowered with information in seconds
BOSTON, Oct. 1, 2024 /PRNewswire/ — TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, today announced the launch of Amadeus, an AI Assistant to help users across the supply chain configure and optimize supply networks. Powered by advanced Large Language Model (LLM) algorithms, Amadeus allows users to find answers across a large volume of the TraceLink University educational content ecosystem, including developer resources, educational “how-to” materials, and technical documentation, delivering detailed, accurate responses tailored to their needs.

Whether navigating through extensive resources, searching for specific content, or exploring related topics, Amadeus provides intelligent answers drawn from a knowledge base refreshed on a daily basis. Its advanced search capabilities and context-aware assistance with source URL and citations ensure a smooth, reliable, current, and efficient content discovery process. With instant access to TraceLink University documents, educational whitepapers, case studies, and more, Amadeus delivers quick, within-seconds responses tailored to specific customer use cases, helping users solve complex business problems with confidence.
“With Amadeus, we are offering a powerful way for customers to engage with the wealth of knowledge within TraceLink University,” said Shabbir Dahod, President and CEO at TraceLink. “By integrating generative AI and LLMs with our extensive content library, Amadeus helps users to quickly find the information they need to optimize their supply chain operations. This is just the beginning of how TraceLink aims to harness AI to further transform supply chain management in the future.”
Amadeus’ AI functionality is further enriched by its robust safeguards. Built-in guardrails and alignment with OpenAI’s safety protocols verify that responses are relevant and accurate, eliminating AI hallucinations and keeping users on track. With these AI safety features built into Amadeus, users receive the most applicable and trusted answers, helping them make informed decisions in real-time. Looking forward, Amadeus will securely integrate content from customers’ own orchestration networks, thereby enabling a powerful AI-driven experience on top of end-to-end supply chain network intelligence to leverage predictions to drive business results.
Learn more about TraceLink’s Opus Magnum release, the only no-code network digitalization platform designed to democratize access to end-to-end supply chain integration and orchestration.
See Opus Magnum live at FutureLink Barcelona 2024, the only thought-leadership, education, and networking event for life sciences and healthcare leaders needing critical intelligence and better collaboration across supply chain relationships, from October 2-4, 2024. With keynotes headlined by the industry’s top thought leaders, a full day of TraceLink University educational sessions, three orchestration tracks led by customers and solution partners, and an immersive product and solution exhibition, this year’s FutureLink will focus on the end-to-end digitalization of your supply chain to link your enterprise systems and processes to the network. Register now.
About TraceLink:
TraceLink Inc. is the largest end-to-end intelligent supply chain platform for life sciences and healthcare, enabling end-to-end orchestration by connecting more than 291,000 healthcare and life sciences entities through its B2N Integrate-Once™ network. Leading businesses trust TraceLink to deliver complete global connectivity, visibility, and traceability of healthcare products, ensuring that every patient gets the medicines they need when needed, safely and securely.
Logo – https://mma.prnewswire.com/media/1004729/TraceLink_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/tracelink-releases-amadeus-the-first-generative-ai-assistant-for-accelerating-the-digitalization-of-supply-networks-on-the-opus-platform-302262931.html

Continue Reading

Trending